FDA approves the first postpartum depression pill

<p>The FDA approved the first pill for postpartum depression on Friday. The drug is called zuranolone, and unlike other antidepressants, it's specifically designated for postpartum depression, a condition that affects around 1 in 7 new mothers.</p><p>The big picture: Zuranolone is taken daily for two weeks. Clinical trials showed that the drug could ease depression in as little as three days.</p> Plus, young workers are redefining the American dream. And, Spanglish is making a comeback. <p>Guests: Axios' Felix Salmon, Arielle Dreher and Marina Franco.</p><p>Credits: Axios Today is produced by Erica Pandey, Alexandra Botti, Fonda...